Epsilon M&A Deal Report - Dr. Vranjes Firenze
Transaction Multiples for the Valuation of Private Companies
L'Occitane International / Dr. Vranjes Firenze
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Cosmetics & Perfumes
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ||||||||
Current |
Multiple available | |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 129
- Number of EMAT Reports / sub-sector « Cosmetics & Perfumes » = 21
Date | Acquirer | Target | Country | Multiples | See details |
29/12/2023 | Private group led by BNP Paribas Développement, Garibaldi Participations and Crédit Agricole Alpes Développement (C2AD) | Distritoys (Groupe King Jouet) | Isère | ** | 115887 |
01/07/2023 | ZEBRA Invest | STRAX European Distribution Business (STRAX Logistics) | Germany | ** | 115549 |
Source: Epsilon Research / EMAT